Chagas disease: an impediment in achieving the Millennium Development Goals in Latin America
- Equal contributors
1 Hospital Infantil de México, Federico Gómez, México D.F
2 Department of Medicine, Emory University School of Medicine, Atlanta GA, USA.3 Centro Trujillano de Investigaciones Parasitológicas José Witremundo Torrealba, Universidad de Los Andes, Trujillo, Venezuela
3 Institutos Nacionales de Salud de Perú, Lima Perú
Citation and License
BMC International Health and Human Rights 2007, 7:7 doi:10.1186/1472-698X-7-7Published: 28 August 2007
Achieving sustainable economic and social growth through advances in health is crucial in Latin America within the framework of the United Nations Millennium Development Goals.
Health-related Millennium Development Goals need to incorporate a multidimensional approach addressing the specific epidemiologic profile for each region of the globe. In this regard, addressing the cycle of destitution and suffering associated with infection with Trypanosoma cruzi, the causal agent of Chagas disease of American trypanosomiasis, will play a key role to enable the most impoverished populations in Latin America the opportunity to achieve their full potential. Most cases of Chagas disease occur among forgotten populations because these diseases persist exclusively in the poorest and the most marginalized communities in Latin America.
Addressing the cycle of destitution and suffering associated with T. cruzi infection will contribute to improve the health of the most impoverished populations in Latin America and will ultimately grant them with the opportunity to achieve their full economic potential.